Prevalence of Human Papillomavirus (HPV) and HPV Type Distribution in Penile Samples in Young Men in Denmark: Results 10 Years After Implementation of a Girls-Only HPV Vaccination Program

J Infect Dis. 2024 Oct 16;230(4):949-956. doi: 10.1093/infdis/jiae068.

Abstract

Background: In Denmark, a girls-only human papillomavirus (HPV) vaccination program was initiated in 2008-2009. The study aim was to assess the HPV prevalence and type distribution in younger men prior to HPV vaccination in men.

Methods: The study population was younger men who attended information days regarding military service. At random days (2019-2020), 280 men were included. We collected questionnaire data regarding risk factors for HPV infection and a penile swab for HPV testing. We compared results in this study with those from a previous study of young men (2006-2007).

Results: The majority of participants (94%) were 18-20 years old. The median number of lifetime sexual partners was 4. Altogether, 130 men (46.4%) were HPV positive. No infections with HPV types 6, 11, 16, 18, 31, and 45 were detected. The most frequent type was HPV-51 (detected in 11.1%). Comparison showed that the odds of high-risk HPV type infection were higher in 2019-2020 (prevalence odds ratio [POR], 1.7 [95% confidence interval {CI}, 1.1-2.7]) compared with 2006-2007. In contrast, the odds were lower (POR, 0.3 [95% CI, .1-.6]) for HPV types targeted by the 9-valent HPV vaccine.

Conclusions: The multicohort girls-only vaccination program has to a large degree protected young men against the HPV types included in the licensed vaccines. This does not speak against gender-neutral vaccination as the HPV prevalence is still high, although consisting largely of less carcinogenic HPV types.

Keywords: HPV vaccination; cross-sectional study; herd protection; human papillomavirus; penile.

MeSH terms

  • Adolescent
  • Adult
  • Denmark / epidemiology
  • Female
  • Human Papillomavirus Viruses
  • Humans
  • Immunization Programs
  • Male
  • Papillomaviridae* / classification
  • Papillomaviridae* / immunology
  • Papillomaviridae* / isolation & purification
  • Papillomavirus Infections* / epidemiology
  • Papillomavirus Infections* / prevention & control
  • Papillomavirus Infections* / virology
  • Papillomavirus Vaccines* / administration & dosage
  • Papillomavirus Vaccines* / immunology
  • Penis / virology
  • Prevalence
  • Risk Factors
  • Surveys and Questionnaires
  • Vaccination / statistics & numerical data
  • Young Adult

Substances

  • Papillomavirus Vaccines